Skip to content
Parker Institute for Cancer Immunotherapy
Search Close

From T-Cell Research to Clinical Impact with Christopher A. Klebanoff, MD

In this episode, physician-scientist Christopher Klebanoff, MD, a PICI Network Investigator at Memorial Sloan Kettering Cancer Center, provides an inside look at his groundbreaking research on optimizing T-cell activation for cancer immunotherapy. Dr. Klebanoff discusses his work on targeting mutated driver oncogenes, expanding cell therapies beyond blood cancers, and using CD4+ T cells to improve cancer outcomes. Tracing the evolution of the field from pioneers like Dr. William Coley to current leaders such as Nobel laureate Jim Allison, PhD, Center Director for the PICI Center at MD Anderson, Dr. Klebanoff explains why multidisciplinary collaboration is essential to driving progress in cancer immunotherapy.

Get ready to go from bench to fireside with Dr. Klebanoff.

Listen on Spotify